Aging-related changes in the nigrostriatal dopamine system and the response to MPTP in nonhuman primates: Diminished compensatory mechanisms as a prelude to parkinsonism

Aging-related changes in the nigrostriatal dopamine system and the response to MPTP in nonhuman primates: Diminished compensatory mechanisms as a prelude to parkinsonism

Aging is the most prominent risk factor for Parkinson’s disease. Yet, consensus of how advancing age may predispose the dopamine (DA) system to parkinsonism is lacking. Three age ranges of female rhesus monkeys, 8–9, 15–17, and 21–31 years, received unilateral DA depletion with intracarotid 1-methyl...

Full description

Bibliographic Details
Main Authors:	Timothy J. Collier, Jack Lipton, Brian F. Daley, Stephane Palfi, Yaping Chu, Caryl Sortwell, Roy A.E. Bakay, John R. Sladek, Jr., Jeffrey H. Kordower
Format:	Article
Language:	English
Published:	Elsevier 2007-04-01
Series:	Neurobiology of Disease
Subjects:	Aging Dopamine Substantia nigra Parkinsonism MPTP Monkey
Online Access:	http://www.sciencedirect.com/science/article/pii/S0969996106003093

Similar Items

Pretreatment with Human Lactoferrin Had a Positive Effect on the Dynamics of Mouse Nigrostriatal System Recovery after Acute MPTP Exposure
by: Marina Yu. Kopaeva, et al.
Published: (2021-01-01)

Amiloride is neuroprotective in an MPTP model of Parkinson's disease
by: Robert L. Arias, et al.
Published: (2008-09-01)

Neuroprotective effect of Lactobacillus plantarum DP189 on MPTP-induced Parkinson's disease model mice
by: Lei Wang, et al.
Published: (2021-10-01)

Increased vulnerability of nigrostriatal terminals in DJ-1-deficient mice is mediated by the dopamine transporter
by: Amy B. Manning-Boğ, et al.
Published: (2007-08-01)

α-Synuclein expression in the substantia nigra of MPTP-lesioned non-human primates
by: Maya G. Purisai, et al.
Published: (2005-12-01)

MPTP and DSP-4 susceptibility of substantia nigra and locus coeruleus catecholaminergic neurons in mice is independent of parkin activity
by: Bobby Thomas, et al.
Published: (2007-05-01)

Age-associated increases of α-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease?
by: Yaping Chu, et al.
Published: (2007-01-01)

Allopregnanolone and Neurogenesis in the Nigrostriatal Tract
by: Junming eWang
Published: (2014-08-01)

Interaction of Neuromelanin with Xenobiotics and Consequences for Neurodegeneration; Promising Experimental Models
by: Andrea Capucciati, et al.
Published: (2021-05-01)

Serotonin 5-HT<sub>4</sub> Receptor Agonists Improve Facilitation of Contextual Fear Extinction in an MPTP-Induced Mouse Model of Parkinson’s Disease
by: Toshiaki Ishii, et al.
Published: (2019-10-01)

Neuroprotective and neurorestorative effects of neuregulins in the injured and aged dopaminergic nigrostriatal system
by: Dickerson, Jonathan W.
Published: (2010)

Evidence for Dysfunction of the Nigrostriatal Pathway in the R6/1 Line of Transgenic Huntington's Disease Mice
by: Å. Petersén, et al.
Published: (2002-10-01)

High Dietary Iron Supplement Induces the Nigrostriatal Dopaminergic Neurons Lesion in Transgenic Mice Expressing Mutant A53T Human Alpha-Synuclein
by: Fengju Jia, et al.
Published: (2018-04-01)

Neonatal exposure to lipopolysaccharide enhances vulnerability of nigrostriatal dopaminergic neurons to rotenone neurotoxicity in later life
by: Lir-Wan Fan, et al.
Published: (2011-12-01)

Effect of Chlorogenic Acid Supplementation in MPTP-Intoxicated Mouse
by: Saumitra S. Singh, et al.
Published: (2018-08-01)

Transforming growth factor beta2 haploinsufficient mice develop age-related nigrostriatal dopamine deficits
by: Zane B. Andrews, et al.
Published: (2006-03-01)

The nigrostriatal system in the presymptomatic and symptomatic stages in the MPTP monkey model: A PET, histological and biochemical study
by: J. Blesa, et al.
Published: (2012-10-01)

Abnormal alpha-synuclein reduces nigral voltage-dependent anion channel 1 in sporadic and experimental Parkinson's disease
by: Yaping Chu, et al.
Published: (2014-09-01)

Comparison of the intranasal and intraperitoneal injection of MPTP on density of dark neurons in pars compacta of substantia nigra in animal model of Parkinson\'s disease
by: Shahi S, et al.
Published: (2015-09-01)

Changes of neurons and blood vessels of human substantia nigra in aging: Morphometric study
by: Krivokuća Zdenka, et al.
Published: (2017-01-01)

5-HT1A receptor agonist-mediated protection from MPTP toxicity in mouse and macaque models of Parkinson's disease
by: Erwan Bezard, et al.
Published: (2006-07-01)

Function and Regulation of ALDH1A1-Positive Nigrostriatal Dopaminergic Neurons in Motor Control and Parkinson’s Disease
by: Kathleen Carmichael, et al.
Published: (2021-05-01)

Activation of tyrosine kinase receptor signaling pathway by rasagiline facilitates neurorescue and restoration of nigrostriatal dopamine neurons in post-MPTP-induced parkinsonism
by: Yotam Sagi, et al.
Published: (2007-01-01)

Reduced noradrenergic innervation of ventral midbrain dopaminergic cell groups and the subthalamic nucleus in MPTP-treated parkinsonian monkeys
by: Gunasingh Jeyaraj Masilamoni, et al.
Published: (2017-04-01)

Mitochondrial DNA mutations in Parkinson's disease brain
by: David K. Simon, et al.
Published: (2017-04-01)

Inter-hemispheric asymmetry of nigrostriatal dopaminergic lesion. A possible compensatory mechanism in Parkinson’s disease
by: Javier eBlesa, et al.
Published: (2011-11-01)

MODERN STEREOLOGICAL EVALUATION IN THE AGING HUMAN SUBSTANTIA NIGRA
by: Shuang Y Ma, et al.
Published: (2011-05-01)

Revising the Role of the Ventrolateral Periaqueductal Gray in the Fear Circuit:
by: Wright, Kristina M.
Published: (2021)

Hydralazine Protects Nigrostriatal Dopaminergic Neurons From MPP+ and MPTP Induced Neurotoxicity: Roles of Nrf2-ARE Signaling Pathway
by: Xingfang Guo, et al.
Published: (2019-03-01)

Time dependent degeneration of the nigrostriatal tract in mice with 6-OHDA lesioned medial forebrain bundle and the effect of activin A on l-Dopa induced dyskinesia
by: Peggy Rentsch, et al.
Published: (2019-02-01)

Is alpha-synuclein loss-of-function a contributor to parkinsonian pathology? Evidence from non-human primates
by: Timothy J Collier, et al.
Published: (2016-01-01)

Quantitative diffusion tensor imaging detects dopaminergic neuronal degeneration in a murine model of Parkinson’s disease
by: Michael D. Boska, et al.
Published: (2007-06-01)

α-synuclein aggregation reduces nigral myocyte enhancer Factor-2D in idiopathic and experimental Parkinson's disease
by: Yaping Chu, et al.
Published: (2011-01-01)

Sirtuin 2 (SIRT2) enhances 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced nigrostriatal damage via apoptotic pathway
by: Lei eLiu, et al.
Published: (2014-08-01)

Lesion of the subthalamic nucleus reverses motor deficits but not death of nigrostriatal dopaminergic neurons in a rat 6-hydroxydopamine-lesion model of Parkinson's disease
by: V. Rizelio, et al.
Published: (2010-01-01)

Subthalamic control of dopamine release in the substantia nigra
by: Barstow, Karen L.
Published: (2019)

Transcranial sonography in Parkinson’s disease
by: I. V. Bayborodina, et al.
Published: (2018-03-01)

Non-linear developmental trajectory of electrical phenotype in rat substantia nigra pars compacta dopaminergic neurons
by: Martial A Dufour, et al.
Published: (2014-10-01)

INTERACTION OF VESICULAR MONOAMINE TRANSPORTER 2 (VMAT2) AND NEUROMELANIN PIGMENT AMONG THE MIDBRAIN DOPAMINERGIC NEURONS, IN MAN
by: P. Pasbakhsh, et al.
Published: (2004-05-01)

INTERACTION OF VESICULAR MONOAMINE TRANSPORTER 2 (VMAT2) AND NEUROMELANIN PIGMENT AMONG THE MIDBRAIN DOPAMINERGIC NEURONS, IN MAN
by: P. Pasbakhsh, et al.
Published: (2004-02-01)